Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group - Hochberg,M.C.; Ross,P.D.; Black,D. (Arthritis Rheum, 1999)